CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm is investigating Cross Country Healthcare, Inc. (NASDAQ: CCRN) for potential securities law violations, focusing on whether the company made false or misleading statements to investors. Shareholders who have incurred losses are encouraged to participate in the investigation by contacting the firm for a free consultation. The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation.
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm is investigating Cross Country Healthcare, Inc. (CCRN) for potential securities law violations due to alleged false and/or misleading statements and failure to disclose pertinent information to investors. Shareholders who have suffered a loss are encouraged to contact the firm to discuss their rights and participate in the fraud investigation. The firm specializes in securities class action lawsuits and shareholder rights litigation globally.
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
Cross Country Healthcare, Inc. announced an exclusive 36-month partnership to integrate the Optimé workforce strategy solution into its Intellify® platform. This integration will enhance Intellify with advanced forecasting, analytics, and workforce optimization capabilities to help health systems better manage staffing, reduce labor costs, and improve resource utilization. This partnership marks a significant step in Cross Country's evolution from a workforce solutions provider to a technology-enabled workforce partner, offering a more predictive and integrated labor strategy for the healthcare market.
Boston Partners holds 7.85% of Cross Country Healthcare (NASDAQ: CCRN)
Boston Partners has disclosed a 7.85% beneficial stake in Cross Country Healthcare (NASDAQ: CCRN), amounting to 2,538,481 shares, as of March 31, 2026. The shares are held in discretionary accounts for clients, with Boston Partners exercising sole voting and dispositive power. This Schedule 13G filing indicates a passive investment.
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
Cross Country Healthcare, Inc. has announced an exclusive 36-month partnership to integrate Optimé, a workforce strategy and planning solution by Strategic Systems International, into its Intellify® platform. This collaboration aims to provide health systems with advanced AI-powered forecasting, analytics, and workforce optimization capabilities to better align staffing with patient demand, improve resource utilization, and reduce labor costs. The partnership signifies Cross Country's evolution into a technology-enabled workforce partner, enhancing Intellify's ability to offer a more proactive and integrated labor strategy for healthcare.
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
Cross Country Healthcare has announced an exclusive 36-month partnership to integrate Strategic Systems International's Optimé solution into its Intellify workforce intelligence platform. This collaboration aims to provide health systems with advanced AI-powered forecasting and optimization capabilities to improve staffing precision, operational efficiency, and labor cost management. The Optimé solution will enhance Intellify by offering a more predictive approach to workforce management, helping health systems align staffing with patient demand and achieve better operational control.
Cross Country Healthcare partners with SSI for workforce platform
Cross Country Healthcare Inc. (NASDAQ:CCRN) has announced a 36-month exclusive partnership with Strategic Systems International to integrate Optimé workforce planning into its Intellify platform. This collaboration aims to enhance workforce optimization and reduce labor costs for health systems by aligning supply with patient demand. The partnership comes as Cross Country Healthcare's stock has seen a 62% year-to-date surge, and follows recent news of its impending acquisition by Knox Lane for $437 million.
Number of shareholders of Cross Country Healthcare, Inc. – NASDAQ:CCRN
This article provides details on the number of shareholders for Cross Country Healthcare, Inc. (NASDAQ: CCRN). It indicates the period, value, change, and percentage change related to the shareholder count. The data is provided by ICE Data Services and FactSet.
Wedbush Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $13.25
Wedbush has reiterated its Hold rating on Cross Country Healthcare (CCRN.US), keeping the target price at $13.25. This indicates the firm's continued neutral stance on the company's stock performance.
Benchmark downgrades Cross Country Healthcare (CCRN)
This article reports that Benchmark has downgraded Cross Country Healthcare (CCRN). The specific details of the downgrade and any new price target are not available in this snippet. Further information would be needed to understand the implications of this rating change.
Cross Country Healthcare (CCRN) Q4 EPS Loss Deepens Challenging Profitability Turnaround Narratives
Cross Country Healthcare (CCRN) reported a Q4 2025 revenue of US$236.8 million and a basic EPS loss of US$2.56, deepening its full-year loss to US$94.9 million. Analysts forecast aggressive earnings growth of 102.9% per year based on cost efficiency and mix shifts, despite largely flat revenue projections. The company's current P/S ratio of 0.4x is significantly lower than industry averages, with a DCF fair value of US$46.81, indicating that future profitability hinges on substantial margin improvement.
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm has announced an investigation into Cross Country Healthcare, Inc. (NASDAQ: CCRN) for potential securities law violations. The firm is looking into whether the company made false or misleading statements and failed to disclose important information to investors. Shareholders who have suffered losses are encouraged to contact The Schall Law Firm to discuss their rights.
Cross Country Healthcare (CCRN) reports Q1 loss, beats revenue estimates
Cross Country Healthcare (CCRN) announced a Q1 loss per share of $0.09, which aligns with analyst estimates. Despite the loss, the company exceeded revenue expectations, reporting $505.7 million against an estimated $505.4 million. This indicates some resilience in its financial performance, particularly on the revenue front.
Cross Country Healthcare to be taken private by PE firm for $437M
Cross Country Healthcare, a staffing technology company, is set to be acquired by private equity firm Knox Lane in an all-cash deal valued at $437 million. This acquisition, which will take the company private, represents a 31% premium over its recent stock price. The deal follows a previously collapsed acquisition attempt by travel nursing agency Aya Healthcare due to antitrust concerns from the Federal Trade Commission.
Cross Country Healthcare to Be Acquired by Knox Lane
Cross Country Healthcare will be acquired by Knox Lane in an all-cash deal valued at approximately $437 million, or $13.25 per share. This transaction, representing a significant premium for shareholders, will take the company private and delist it from Nasdaq, with closing expected in Q3 2026 pending regulatory approvals. The acquisition aims to leverage Cross Country's AI-enabled staffing platform and healthcare relationships, while the company has canceled its earnings call and shareholder meeting to focus on the sale.
Cross Country Healthcare (NASDAQ: CCRN) posts Q1 2026 loss, agrees $13.25 cash buyout
Cross Country Healthcare (CCRN) reported a first-quarter 2026 net loss of $4.3 million on revenue of $241.1 million, a 17.8% year-over-year decrease largely due to lower volumes in both Nurse and Allied Staffing and Physician Staffing segments. Following the quarter, the company announced a definitive agreement to be acquired by KL Criss Cross Intermediate, LLC for $13.25 per share in cash, which will take the company private upon closing. Despite the loss, CCRN maintains a strong cash position of $105.6 million with no ABL borrowings, and a substantial portion of its share repurchase program remains.
Cross Country Healthcare Agrees to $437 Million Cash Buyout By Knox Lane
Cross Country Healthcare has agreed to be acquired by private equity firm Knox Lane for approximately $437 million in cash. Shareholders will receive $7.50 per share, representing a 20% premium over the closing price on Wednesday. The deal is expected to close in Q4 2024, subject to shareholder and regulatory approvals.
Cross Country: Q1 Earnings Snapshot
Cross Country Healthcare Inc. (CCRN) reported a first-quarter loss of $4.3 million, or 14 cents per share. Adjusted losses were 3 cents per share, which exceeded Wall Street expectations. The company also surpassed revenue forecasts, posting $241.1 million for the period.
Cross Country (NASDAQ: CCRN) Q1 revenue falls 18% amid pending sale
Cross Country Healthcare (CCRN) reported a Q1 2026 revenue of $241.1 million, an 18% decrease year-over-year but a 2% sequential increase, signaling stabilization after an industry slowdown. The company posted a net loss of $4.3 million and generated $3.9 million in Adjusted EBITDA. CCRN also announced a pending merger with KL Criss Cross Intermediate, after which its stock is expected to be delisted and deregistered.
Cross Country Healthcare Up Over 29%, on Pace for Largest Percent Increase Since December 2024 -- Data Talk
Cross Country Healthcare's stock price has surged over 29%, putting it on track for its largest percentage increase since December 2024. The volume of shares traded also significantly exceeded its 10-day average. The company's EPS growth in Q3 2025 was 40% year-over-year, and it is scheduled to report its next earnings on February 26, 2026.
Cross Country Healthcare stock surges on Knox Lane buyout deal
Cross Country Healthcare Inc. (NASDAQ: CCRN) shares surged 29% after announcing it will be acquired by Knox Lane, a growth-oriented investment firm, in an all-cash transaction. The deal values the company at $437 million, with shareholders receiving $13.25 per share, representing a significant premium over recent trading prices. Upon completion, expected in Q3 2026, Cross Country Healthcare will become a privately held company under the Knox Lane portfolio.
Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million
Cross Country Healthcare (NASDAQ: CCRN), a healthcare workforce solutions company, announced it will be acquired by Knox Lane, a growth-oriented investment firm, in an all-cash transaction valued at $437 million. Stockholders will receive $13.25 per share, representing premiums of 31% and 45% over recent trading prices. The transaction is expected to close in Q3 2026, after which Cross Country Healthcare will become a privately held company under the same name.
Cross Country Healthcare to Be Acquired by Knox Lane
Cross Country Healthcare has agreed to an all-cash acquisition by Knox Lane for $437 million, or $13.25 per share, representing a significant premium to its recent trading prices. The deal, expected to close in Q3 2026, will take the company private and delist it from Nasdaq, with customary closing conditions including regulatory approvals. Knox Lane aims to leverage Cross Country's AI-enabled staffing platform and expand its market position in healthcare workforce solutions.
Cross Country Healthcare to go private in $437M deal with Knox Lane
Knox Lane is set to acquire Cross Country Healthcare in a $437 million deal, taking the company private. The acquisition was announced on May 7, 2026. This move signifies a significant change for Cross Country Healthcare's ownership structure.
Cross Country Healthcare to go private in $437M deal with Knox Lane
Cross Country Healthcare will be acquired by Knox Lane in a $437 million deal, taking the company private. The news was reported by Hayley DeSilva in Modern Healthcare on May 7, 2026. This acquisition signifies a major change in the ownership structure of Cross Country Healthcare.
Knox Lane to acquire Cross Country Healthcare (NASDAQ: CCRN) for $13.25 cash
Knox Lane will acquire Cross Country Healthcare (NASDAQ: CCRN) in an all-cash transaction valued at $437 million, with stockholders receiving $13.25 per share. This represents a 31% premium to the last closing price and a 45% premium to the 90-day volume-weighted average price. The merger is subject to stockholder and regulatory approvals and is expected to close in Q3 2026, leading to Cross Country Healthcare becoming a private entity and being delisted from Nasdaq.
Press Release: Cross Country Healthcare to Be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million
Cross Country Healthcare (NASDAQ: CCRN) has agreed to be acquired by private equity firm Knox Lane in an all-cash transaction valued at approximately $437 million. Stockholders will receive $29.00 per share. The deal, which aims to take the company private, is expected to close in the second half of 2026, subject to customary closing conditions and stockholder approval.
Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million
Cross Country Healthcare, Inc. will be acquired by Knox Lane in an all-cash transaction valued at $437 million. Shareholders will receive $13.25 per share, representing a significant premium over recent trading prices. The acquisition is expected to close in Q3 2026, after which Cross Country Healthcare will become a privately held company under the Knox Lane portfolio.
Knox Lane to acquire Cross Country Healthcare for $437 million By Investing.com
Knox Lane, a San Francisco-based investment firm, is set to acquire Cross Country Healthcare Inc. in an all-cash transaction valued at $437 million, or $13.25 per share. This offer represents a significant premium to Cross Country Healthcare's recent trading prices. The acquisition will result in Cross Country Healthcare becoming a privately held company under Knox Lane, while retaining its name and brand.
Knox Lane to acquire Cross Country Healthcare for $437 million
Knox Lane, a San Francisco-based investment firm, is set to acquire Cross Country Healthcare Inc. (NASDAQ:CCRN) in an all-cash transaction valued at $437 million. This offer of $13.25 per share represents a significant premium over recent trading prices, though InvestingPro analysis suggests the company may still be undervalued. Following the acquisition, Cross Country Healthcare will become a privately held company within Knox Lane's portfolio.
Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million
Cross Country Healthcare is set to be acquired by Knox Lane in an all-cash transaction valued at $437 million. This announcement was reported by Quantisnow, a platform providing real-time market data and news for retail investors. The acquisition details were released via a PR statement.
Cross Country Healthcare, FAU release 2026 State of Nursing report
Cross Country Healthcare and Florida Atlantic University (FAU) have released their fifth annual "Purpose Under Pressure: The State of Nursing in 2026" report, revealing a resilient but increasingly strained nursing workforce. The study, based on insights from over 2,000 nurses and nursing students, highlights that while nurses remain deeply committed to making a difference, pressures such as burnout, pay concerns, and feeling undervalued have significantly increased since 2022. The report calls on healthcare leaders to respond to these challenges with greater flexibility, support, and a focus on retention and sustainable practices.
Cross Country Healthcare Marks 40 Years, Accelerates Next Generation of Workforce Intelligence and Orchestration
Cross Country Healthcare is celebrating its 40th anniversary by accelerating its investment in workforce intelligence, expanding the use of embedded AI and predictive analytics across its contingent workforce operations. The company's proprietary Intellify® platform aims to connect labor data for real-time visibility, forecasting, and optimization, moving from a staffing provider to a technology-enabled workforce partner. This approach leverages four decades of healthcare labor data to help health systems make faster decisions, lower costs, and enhance workforce execution.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Receives Average Recommendation of "Hold" from Brokerages
Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received an average recommendation of "Hold" from brokerage firms, with analysts setting an average 12-month price target of $12.53. The company recently reported Q4 earnings of ($0.06) EPS, missing consensus estimates, and had revenue of $236.8 million against an expected $254.3 million. Institutional ownership stands at 96.03%, with firms like AllianceBernstein and Goldman Sachs increasing their stakes.
Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Biogen (BIIB) and Cross Country Healthcare (CCRN)
Healthcare analysts have issued new ratings for Cullinan Management (CGEM), Biogen (BIIB), and Cross Country Healthcare (CCRN). Wedbush maintained a Buy rating for Cullinan Management with a $36.00 price target and a Hold rating for Biogen with a $191.00 price target. Cross Country Healthcare also received a reiterated Buy rating with a $15.00 price target from Wedbush.
Wedbush Maintains Cross Country Healthcare(CCRN.US) With Buy Rating, Maintains Target Price $15
Wedbush has reiterated its Buy rating on Cross Country Healthcare (CCRN.US), maintaining a target price of $15. This continued positive outlook suggests the firm believes in the company's sustained performance and future growth prospects.
Cross Country Healthcare Marks 40 Years, Accelerates Next Generation of Workforce Intelligence and Orchestration
Cross Country Healthcare celebrates its 40th anniversary by accelerating investment in workforce intelligence, leveraging embedded AI and predictive analytics. The company's Intellify® platform is central to this transformation, moving from a staffing provider to a technology-enabled workforce partner by offering real-time visibility, forecasting, and optimization for healthcare systems. This expansion into high-growth markets like locums and home-based care aims to provide precise workforce execution, lower costs, and enhance decision-making in complex healthcare environments.
People on the move: Cross Country, Spencer Stuart, Bullhorn and more
This article details recent leadership appointments and changes at several companies in the staffing and workforce solutions industry. Key moves include Chris Tyrell and Darrick Sogabe joining Cross Country Healthcare as CIO and CPO, respectively; Bill Launder becoming Spencer Stuart's first Chief Communications Officer; and promotions at Bullhorn for Jason Heilman and Ryan Murphy. Additionally, Premier Health of America announced Jean-Robert Pronovost's departure as VP, corporate development, and Per Scholas added Charles Song and Paul Bajus to its board.
Cross Country Healthcare names Darrick Sogabe chief product officer
Cross Country Healthcare, Inc. (NASDAQ:CCRN) has appointed Darrick Sogabe as its new Chief Product Officer. Sogabe, who previously architected the company's Intellify platform, will now lead product strategy and development, focusing on integrating various workforce management solutions. This move is part of the company's broader strategy to enhance its digital platforms and strengthen its position in healthcare workforce solutions.
Cross Country Names Darrick Sogabe Chief Product Officer to Expand Healthcare Technology Portfolio
Cross Country Healthcare has appointed Darrick Sogabe as Chief Product Officer to lead the expansion of its healthcare technology portfolio and workforce technology development. Sogabe will oversee enterprise product strategy and innovation, focusing on advancing the company's Intellify platform. This move aims to enhance data-driven workforce management solutions for health systems, addressing staffing shortages and optimizing labor costs.
Cross Country Appoints Darrick Sogabe as Chief Product Officer, Advancing the Company’s Growing Technology Portfolio
Cross Country Healthcare, Inc. has appointed Darrick Sogabe as Chief Product Officer to lead the company's product strategy, platform innovation, and enterprise growth, particularly for its Intellify® platform. Sogabe, an architect of Intellify®, will focus on enhancing the platform to connect contingent labor, compliance, scheduling, and workforce analytics using agentic AI. This appointment reinforces Cross Country's strategy as a technology-driven workforce solutions leader.
The architect of Cross Country’s Intellify platform just became product chief
Cross Country Healthcare, Inc. (Nasdaq: CCRN) has appointed Darrick Sogabe as Chief Product Officer, recognizing his pivotal role as the architect of their Intellify® cloud-based workforce intelligence platform. In his new capacity, Sogabe will lead the product strategy and roadmap development across the enterprise, focusing on enhancing Intellify beyond traditional VMS platforms by integrating contingent labor, compliance, scheduling, and workforce analytics with agentic AI. This move underscores Cross Country's strategic commitment to leveraging technology and AI to optimize healthcare workforce management and improve operational efficiencies for health systems.
Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy (2026-04-21)
Cross Country Healthcare, Inc. has announced the appointment of Chris Tyrell as Chief Information Officer to lead its next phase of enterprise technology investment. Tyrell will focus on advancing the company's AI, automation, and platform strategy, including the expansion of its Intellify® workforce intelligence platform. This move underscores Cross Country's commitment to leveraging technology as a growth lever and competitive advantage in healthcare workforce solutions.
Cross Country Healthcare names Chris Tyrell as CIO
Cross Country Healthcare (NASDAQ: CCRN) has appointed Chris Tyrell as its new Chief Information Officer to lead the company's enterprise technology organization. Tyrell, with over 20 years of executive technology leadership experience, will focus on advancing the company's Intellify platform, cybersecurity, and AI enablement. The company's stock has risen nearly 23% year-to-date, and analysts predict a return to profitability this year, despite recent Q4 2025 earnings falling short of expectations.
Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy
Cross Country Healthcare, Inc. (Nasdaq: CCRN) has appointed Chris Tyrell as Chief Information Officer to lead its next phase of enterprise technology investment, focusing on AI, automation, and platform strategy. Tyrell, with over 20 years of executive technology leadership experience, will be responsible for strengthening the company's technology infrastructure and accelerating innovation, including the expansion of its Intellify® platform. This appointment underscores Cross Country's commitment to building an intelligent, integrated, and AI-driven operating model to enhance workforce solutions delivery and maintain a technological advantage.
Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy
Cross Country Healthcare has announced the appointment of Chris Tyrell as Chief Information Officer to advance its enterprise technology investment and AI, automation, and platform strategy. Tyrell, with over 20 years of executive technology leadership, will focus on strengthening the company's Intellify® platform and digital infrastructure. His role emphasizes technology as a growth lever to build a more connected, intelligent, and scalable enterprise.
Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy
Cross Country Healthcare, Inc. has appointed Chris Tyrell as Chief Information Officer to lead its next phase of enterprise technology investment, focusing on AI, automation, and platform strategy. Tyrell brings over 20 years of experience in executive technology leadership across various sectors. His role will involve strengthening the company's technology backbone and accelerating innovation as Cross Country expands its Intellify® platform and scales broader enterprise capabilities.
Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy
Cross Country Healthcare, Inc. has announced the appointment of Chris Tyrell as Chief Information Officer. Tyrell will lead the company's enterprise technology organization, focusing on AI enablement, platform integration, cybersecurity, and digital transformation to strengthen its technology backbone and accelerate innovation. This appointment reflects Cross Country's commitment to building a more intelligent, integrated, and future-ready AI-driven operating model, expanding its workforce intelligence platform, InteliHire®.
New CIO takes over cybersecurity, AI and digital overhaul at Cross Country
Cross Country Healthcare, Inc. has appointed Chris Tyrell as its new Chief Information Officer to spearhead the company's enterprise AI and platform strategy. Tyrell will be responsible for infrastructure, systems modernization, platform integration, cybersecurity, AI enablement, and digital transformation, enhancing the company’s Intellify® platform and overall technology roadmap. This strategic hire underscores Cross Country's commitment to leveraging technology as a core driver for growth, efficiency, and competitive advantage in the healthcare workforce solutions sector.
Cross Country Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026
Cross Country Healthcare, Inc. (Nasdaq: CCRN) will host a conference call on Thursday, May 7, 2026, at 5:00 P.M. Eastern Time, to discuss its first-quarter 2026 financial results. The earnings press release will be distributed after market close on the same day. A live webcast and replay options will be available via the company's investor relations website.
